NEW YORK (AP) — Teva Pharmaceutical Industries Ltd. said Tuesday the Food and Drug Administration approved its generic version of the heartburn drug Prevacid. Teva will sell 15-milligram and 30-milligram delayed-release capsule versions of the drug. Teva said the branded version of Prevacid had sales of about $2.97 billion in the 12 months ended June 30.
